Scientists discover why AstraZeneca jab is linked to rare blood clot complications

Scientists may have found the “trigger” behind the incredibly rare blood clot complications stemming from the Oxford/AstraZeneca vaccine.

An international team of researchers from Cardiff and the US have found that a protein in the blood is attracted to a component in the vaccine.

They believe this may spark a chain reaction in the immune system which can culminate in the development of blood clots – a condition known as vaccine-induced immune thrombotic thrombocytopenia (VITT).